These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 26523107)

  • 21. Importance of optical diagnosis in early gastric cancer: A case report of early gastric signet ring cell carcinoma.
    Akabah PS; Mocan S; Molnar C; Dobru D
    Niger J Clin Pract; 2017 Oct; 20(10):1342-1345. PubMed ID: 29192642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with detection of hereditary diffuse gastric cancer on endoscopy in individuals with germline CDH1 mutations.
    Laszkowska M; Tang L; Vos E; King S; Salo-Mullen E; Magahis PT; Abate M; Catchings A; Zauber AG; Hahn AI; Schattner M; Coit D; Stadler ZK; Strong VE; Markowitz AJ
    Gastrointest Endosc; 2023 Sep; 98(3):326-336.e3. PubMed ID: 37094689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant chemotherapy
    Li Y; Ma FH; Xue LY; Tian YT
    World J Gastroenterol; 2020 Feb; 26(8):818-827. PubMed ID: 32148379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
    Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK
    Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
    Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
    Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving survival of stage II-III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy.
    Li Y; Zhu Z; Ma F; Xue L; Tian Y
    Cancer Med; 2020 Sep; 9(18):6617-6628. PubMed ID: 32744431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study.
    Pernot S; Dubreuil O; Aparicio T; Le Malicot K; Tougeron D; Lepère C; Lecaille C; Marthey L; Palle J; Bachet JB; Zaanan A; Taieb J
    Br J Cancer; 2018 Aug; 119(4):424-428. PubMed ID: 29872148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma.
    Sentani K; Oue N; Tashiro T; Sakamoto N; Nishisaka T; Fukuhara T; Taniyama K; Matsuura H; Arihiro K; Ochiai A; Yasui W
    Am J Surg Pathol; 2008 Aug; 32(8):1182-9. PubMed ID: 18580680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?
    Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K
    Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological features and outcomes in patients undergoing radical resection for early gastric cancer with signet ring cell histology.
    Wang Z; Zhang X; Hu J; Zeng W; Zhou Z
    J Visc Surg; 2015 Dec; 152(6):357-61. PubMed ID: 26481069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model.
    Yamaguchi K; Yoshihiro T; Ariyama H; Ito M; Nakano M; Semba Y; Nogami J; Tsuchihashi K; Yamauchi T; Ueno S; Isobe T; Shindo K; Moriyama T; Ohuchida K; Nakamura M; Nagao Y; Ikeda T; Hashizume M; Konomi H; Torisu T; Kitazono T; Kanayama T; Tomita H; Oda Y; Kusaba H; Maeda T; Akashi K; Baba E
    Gastric Cancer; 2022 Sep; 25(5):862-878. PubMed ID: 35661943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological features and cancer transcriptomic profiling of poorly cohesive gastric carcinoma subtypes.
    Yen HH; Chen PY; Huang RY; Jeng JM; Lai IR
    J Pathol Clin Res; 2024 Jul; 10(4):e12387. PubMed ID: 38860888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Confocal endomicroscopy diagnostic criteria for early signet-ring cell carcinoma in hereditary diffuse gastric cancer.
    Pilonis ND; O'Donovan M; Richardson S; Fitzgerald RC; di Pietro M
    BMC Gastroenterol; 2023 May; 23(1):176. PubMed ID: 37221458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer.
    Shi C; Yang B; Chen Q; Yang J; Fan N
    Oncology; 2011; 80(5-6):289-95. PubMed ID: 21778768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: III. Expressions of EMA, CEA, CA19-9, CDX-2, p53, Ki-67 antigen, TTF-1, vimentin, and p63 in normal mucosa and in 42 cases.
    Terada T
    Int J Clin Exp Pathol; 2013; 6(4):630-8. PubMed ID: 23573309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microangiopathic Hemolytic Anemia Is a Late and Fatal Complication of Gastric Signet Ring Cell Carcinoma: A Systematic Review and Case-Control Study.
    Lam R; Tarangelo N; Wang R; Horibe M; Grimshaw AA; Jain D; Haffar S; Bazerbachi F; Kunz PL; Li DK
    Oncologist; 2022 Sep; 27(9):751-759. PubMed ID: 35589098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
    Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
    Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deep Learning Models for Gastric Signet Ring Cell Carcinoma Classification in Whole Slide Images.
    Kanavati F; Ichihara S; Rambeau M; Iizuka O; Arihiro K; Tsuneki M
    Technol Cancer Res Treat; 2021; 20():15330338211027901. PubMed ID: 34191660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early signet ring cell carcinoma of the stomach is related to favorable prognosis and low incidence of lymph node metastasis.
    Imamura T; Komatsu S; Ichikawa D; Kawaguchi T; Kosuga T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Otsuji E
    J Surg Oncol; 2016 Oct; 114(5):607-612. PubMed ID: 27562147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic Profiling of Gastric Signet Ring Cell Carcinoma Tissues Reveals Characteristic Changes of the Complement Cascade Pathway.
    Fan Y; Bai B; Liang Y; Ren Y; Liu Y; Zhou F; Lou X; Zi J; Hou G; Chen F; Zhao Q; Liu S
    Mol Cell Proteomics; 2021; 20():100068. PubMed ID: 33676000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.